Evidence map›Paper›PMID 29461134›Full record

Trial reportSubstance use & misuse2018

Correlates of Validity of Self-Reported Methamphetamine Use among a Sample of Dependent Adults.

Christopher Rowe, Eric Vittinghoff, Grant Colfax, Phillip O Coffin, Glenn-Milo Santos

Abstract readRandomized Controlled TrialValidation Study
In one paragraph

Trial report in Substance use & misuse, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christopher Rowea Substance Use Research Unit, San Francisco Department of Public Health , San Francisco , California , USA.
Eric Vittinghoffb Department of Epidemiology and Biostatistics , University of California , San Francisco , California , USA.
Grant Colfaxc Department of Health and Human Services , County of Marin , San Rafael , California , USA.
Phillip O Coffina Substance Use Research Unit, San Francisco Department of Public Health , San Francisco , California , USA.
Glenn-Milo Santosa Substance Use Research Unit, San Francisco Department of Public Health , San Francisco , California , USA.ORCID 0000-0003-1009-5317

Funding

Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Aripiprazole to reduce methamphetamine use among MSM with high-risk HIV behaviorsR01DA023387 · NIDA · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI COFFIN, PHILLIP O · 2007 to 2011
$1.0M
NIDA NIH HHS R01 DA023387
6 · The paper itself

Abstract

backgroundSelf-reported data are widely used in substance-use research, yet few studies have assessed the validity of self-reported methamphetamine use compared to biological assays.

objectivesWe sought to assess the validity and correlates of validity of self-reported methamphetamine use compared to urine toxicology (UTOX).

methodsUsing a sample of methamphetamine-dependent individuals enrolled in a randomized controlled pharmacotherapy trial in the United States (n = 327 visits among 90 participants), we calculated sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and the kappa coefficient of self-reported methamphetamine use in the past 3 days compared to UTOX, as well as the NPV of self-reported methamphetamine use over an extended recall period of 1 month. We used multivariable logistic regression models to assess correlates of concordance between self-reported methamphetamine use and UTOX.

resultsThe sensitivity of self-reported methamphetamine use in the past 3 days was 86.7% (95% confidence intervals (95%CI): 81.4%-91.4%), the specificity was 85.3% (77.7-91.3), the PPV was 91.5% (86.9-94.8), and the NPV was 78.0% (69.4-86.1), compared to UTOX (kappa = 0.71). The NPV over the extended recall period was 70.6% (48.0-85.7). In multivariable analyses, validity of self-reported methamphetamine use was higher for older participants but lower during follow-up compared to baseline and when polysubstance use or depressive symptoms were reported. Conclusions/Importance: Our sample of methamphetamine-dependent adults reported recent methamphetamine use with high validity compared to UTOX. Validity increased with age but decreased when participants reported depressive symptoms or polysubstance use as well as later in the study timeline and during longer recall periods.

Indexed as

AdolescentAdultAge DistributionCentral Nervous System StimulantsHumansLogistic ModelsMethamphetamineMiddle AgedSan FranciscoSelf ReportSensitivity and SpecificitySubstance Abuse DetectionSubstance-Related DisordersYoung AdultCentral Nervous System StimulantsMethamphetamineMethamphetamineself-reportsubstance-use researchurine toxicologyvalidity

Identifiers

PMID29461134
PMCPMC6530983

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.